Investor's Fiduciary Advisor Network’s AbbVie ABBV Stock Holding History

Investor's Fiduciary Advisor Network’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$863K	Sell	3,431 -209	-6%	-$45K	0.29%	84
2026 Q1	$791K	Sell	3,640 -105	-3%	-$23.3K	0.24%	109
2025 Q4	$855K	Sell	3,745 -898	-19%	-$205K	0.18%	125
2025 Q3	$1.07M	Buy	4,643 +42	+0.9%	+$8.55K	0.36%	80
2025 Q2	$854K	Buy	+4,601	New	+$855K	0.32%	85
2025 Q1	–	Sell	-4,833	Closed	-$858K	–	167
2024 Q4	$858K	Buy	+4,833	New	+$889K	0.33%	79

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Investor's Fiduciary Advisor Network's ABBV Position: Q2 2026 in Review

Investor's Fiduciary Advisor Network reduced its AbbVie (ABBV) stake by 5.7% in Q2 2026, selling an estimated $45K and leaving 3,431 shares worth $863K. The position accounts for 0.29% of the portfolio, ranked #84.

Investor's Fiduciary Advisor Network first reported a position in ABBV in Q4 2024 and has held it in 6 quarters since. The position peaked at $1.07M in Q3 2025. 4,195 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Investor's Fiduciary Advisor Network held 3,431 shares of AbbVie worth $863K as of Q2 2026.
Investor's Fiduciary Advisor Network sold 209 AbbVie shares in Q2 2026, an estimated $45K.
AbbVie made up 0.29% of Investor's Fiduciary Advisor Network's portfolio in Q2 2026, its #84 holding.
Investor's Fiduciary Advisor Network first reported a position in AbbVie in Q4 2024 and has held it in 6 quarters since.
Investor's Fiduciary Advisor Network's AbbVie position peaked at $1.07M in Q3 2025.
4,195 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Investor's Fiduciary Advisor Network's 13F filing for Q2 2026, filed 13 Aug 2026.